X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126) 126
index medicus (114) 114
administration, inhalation (87) 87
anti-bacterial agents - administration & dosage (81) 81
ventilator-associated pneumonia (75) 75
aerosolized colistin (67) 67
antibiotics (59) 59
colistin (59) 59
pneumonia (59) 59
pharmacology & pharmacy (57) 57
pseudomonas-aeruginosa (55) 55
cystic fibrosis (54) 54
anti-bacterial agents - therapeutic use (52) 52
aerosolized antibiotics (51) 51
nosocomial pneumonia (47) 47
infectious diseases (46) 46
gram-negative bacteria (44) 44
respiratory system (44) 44
cystic-fibrosis (43) 43
female (43) 43
male (43) 43
pseudomonas aeruginosa (43) 43
pneumonia, ventilator-associated - drug therapy (41) 41
treatment outcome (41) 41
pseudomonas infections - drug therapy (40) 40
microbiology (39) 39
colistin - administration & dosage (38) 38
intravenous colistin (38) 38
aerosolized tobramycin (33) 33
bacterial pneumonia (32) 32
infections (32) 32
pseudomonas aeruginosa - drug effects (30) 30
drug therapy (29) 29
tobramycin (29) 29
aerosols (28) 28
nebulizers and vaporizers (28) 28
therapy (28) 28
critical care medicine (26) 26
intensive-care-unit (26) 26
retrospective studies (26) 26
colistin - therapeutic use (24) 24
drug resistance, multiple, bacterial (24) 24
middle aged (24) 24
pharmacokinetics (24) 24
adult (23) 23
critically-ill patients (23) 23
health aspects (22) 22
inhalation (22) 22
acinetobacter baumannii (21) 21
dosage and administration (21) 21
anti-bacterial agents - pharmacokinetics (20) 20
cystic fibrosis - complications (20) 20
pneumonia, bacterial - drug therapy (20) 20
respiratory tract infections - drug therapy (20) 20
acinetobacter infections - drug therapy (19) 19
aged (19) 19
mortality (19) 19
pneumonia, ventilator-associated - microbiology (19) 19
pseudomonas infections - microbiology (19) 19
acinetobacter-baumannii (18) 18
amikacin (18) 18
care and treatment (18) 18
inhaled colistin (18) 18
animals (17) 17
cystic-fibrosis patients (17) 17
drug delivery systems (17) 17
inhaled antibiotics (17) 17
tobramycin - administration & dosage (17) 17
antimicrobial agents (16) 16
cystic fibrosis - drug therapy (16) 16
drugs (16) 16
efficacy (16) 16
inhaled tobramycin (16) 16
research (16) 16
anti-bacterial agents - adverse effects (15) 15
antibacterial agents (15) 15
drug resistance in microorganisms (15) 15
pseudomonas aeruginosa - isolation & purification (15) 15
resistant acinetobacter-baumannii (15) 15
analysis (14) 14
anti-bacterial agents - pharmacology (14) 14
cross infection - drug therapy (14) 14
drug resistance (14) 14
infection (14) 14
intensive care units (14) 14
acinetobacter baumannii - drug effects (13) 13
adjunctive therapy (13) 13
aerosolized (13) 13
safety (13) 13
bronchiectasis (12) 12
cystic fibrosis - microbiology (12) 12
gram-negative bacterial infections - drug therapy (12) 12
immunology (12) 12
inhaled aztreonam lysine (12) 12
mechanical ventilation (12) 12
pediatrics (12) 12
respiratory-tract (12) 12
vehicles (12) 12
biochemical phenomena, metabolism, and nutrition (11) 11
child (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 09/2012, Volume 101, Issue 9, pp. 3347 - 3359
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2008, Volume 103, Issue 5, pp. 707 - 713
Summary Background Reports of patients with polymyxin-only susceptible gram-negative nosocomial pneumonia treated with inhaled, but without concurrent... 
Pulmonary/Respiratory | Pseudomonas aeruginosa | Ventilator-associated pneumonia | Acinetobacter baumannii | Polymyxin | ICU-acquired pneumonia | RESPIRATORY-TRACT | ANTIBIOTICS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | ANTIMICROBIALS | NEGATIVE BACTERIAL-INFECTIONS | AEROSOLIZED COLISTIN | POLYMYXIN-B | RESPIRATORY SYSTEM | PSEUDOMONAS-AERUGINOSA | CYSTIC-FIBROSIS | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Acinetobacter Infections - drug therapy | Administration, Inhalation | Colistin - administration & dosage | Gram-Negative Bacterial Infections - drug therapy | Male | Treatment Outcome | Cross Infection - drug therapy | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Adolescent | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Female | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Pneumonia, Ventilator-Associated - drug therapy | Drug resistance in microorganisms | Pneumonia | Cross infection | Nosocomial infections | Antibacterial agents | Bacterial pneumonia | Ventilators | Heart attacks | Mortality | Ventilation | Bacteria | Antimicrobial agents | Infections | Gram-negative bacteria | Drug therapy | Blood
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 7/2010, Volume 36, Issue 7, pp. 1147 - 1155
Journal Article